ABBOTT LABORATORIES (ABT) Cash flow statement
Top 12 of 27 line items reported by ABT · 250+ in the full API →
ABBOTT LABORATORIES (ABT) · Cash Flow Statement
Consolidated Statements of Cash Flows
Annual · In millions USD, except per-share data · Latest filed Feb 20, 2026 · FY ends Dec 31
| Fiscal Years Ended | |||||
|---|---|---|---|---|---|
FY2025 Dec 31, 2025 | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 | Trend | |
| Net Cash Flow from Operating Activities | $9,566 | $8,558 | $7,261 | $9,581 | |
| Net Income | 6,524 | 13,402 | 5,723 | 6,933 | |
| Net Cash Flow from Investing Activities | $(2,422) | $(2,338) | $(3,133) | $(1,740) | |
| Capital Expenditures | -2,171 | -2,207 | -2,202 | -1,777 | |
| Other Investing Activities | (-18) | (-9) | (-22) | (-22) | |
| Net Cash Flow from Financing Activities | $(6,309) | $(5,404) | $(7,091) | $(7,636) | |
| Common stock repurchased | -893 | -1,295 | -1,227 | -3,795 | |
| Dividends Paid | -4,116 | -3,836 | -3,556 | -3,309 | |
| Other financing activities | (82) | 0 | 0 | 0 | |
| Effect of Exchange Rate Changes | 71 | (96) | (23) | (122) | |
| Net Cash Flow | $906 | $720 | $(2,986) | $83 | |
| Free Cash Flow | 7,395 | 6,351 | 5,059 | 7,804 | |
15 more line items available via the API
Depreciation & AmortizationStock-Based CompensationAccounts receivableInventoriesOther current assetsAccounts payableIncome taxes payablePurchases of investmentsNet Debt Issued (Repaid)Total debt issuedShort-term debt issuedLong-term debt issuedTotal debt repaidShort-term debt repaidLong-term debt repaid